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Abstract
Purpose—Treatment of metastatic colorectal carcinoma represents a major clinical challenge.
We investigated the hypothesis that the desmoplastic reaction within liver elicited by metastatic
adenocarcinoma, characterised by collagen I deposition and altered collagen IV distribution,
promotes growth and survival of hepatic colorectal carcinoma metastases.
Experimental design—Partial hepatectomy specimens for metastatic colorectal
adenocarcinoma were examined immunohistochemically for differential integrin expression.
Human colorectal adenocarcinoma cell lines HT-29, KM12SM and KM12c were grown on wild
type collagen I or IV, or cleavage resistant r/r collagen I, and assessed for their growth, survival
and resistance to 5-fluorouracil. The effect of αvβ3 and αvβ5 integrin blockade by neutralising
antibodies was examined.
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Statement of Clinical Relevance
Colorectal carcinoma (CRC) affects 5% of adults in the West. 50% of those who undergo a potentially curative resection die within 5
years, the majority due to metastatic disease. Surgery is the only available curative treatment for hepatic CRC metastases but only
10-20% of patients are operable at presentation. 70% of patients develop a recurrence within the first year after hepatectomy, and the 5
year survival is 26-49%. The need for targeted strategies is clear, and an understanding of the biological behaviour of metastatic CRC
in the liver is essential to inform their development.
The desmoplastic reaction associated with invasive malignancy is characterised by an accumulation of fibrillar collagens. In primary
malignancy these changes benefit the tumour. To date, little is known about this in metastatic disease.
Our studies demonstrate the importance of a desmoplastic reaction to hepatic CRC metastases. Contact with collagen I, a major
component of this desmoplastic reaction, gives CRC cells a growth and survival advantage, and increased chemoresistance.
Expression of integrins by colorectal carcinoma and turnover of collagen I enhances growth. This suggests that targeting the integrin-
matrix interactions in hepatic colorectal carcinoma metastases may present a specific therapeutic opportunity.
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Results—Collagen I, in contrast to collagen IV, significantly enhanced the growth, survival and
chemoresistance of colorectal carcinoma cells. αvβ3 and αvβ5 integrin blockade significantly
reduced colorectal carcinoma cell proliferation on collagen, especially in the cell line with most
metastatic potential. These in vitro findings correlated with the pattern of integrin expression
identified within resected hepatic colorectal carcinoma metastases. Using matrix
metalloproteinase-resistant r/r collagen I as a dominant negative ligand for αv integrins we
demonstrated a key role for this integrin-ligand interaction in mediating the survival and
proliferation of colorectal carcinoma cells.
Conclusions—Desmoplasia has an important role in the development of hepatic colorectal
carcinoma metastasis. The interaction between integrin and collagen I is identified as a potential
therapeutic target.
Introduction
Colorectal carcinoma is the second commonest neoplasm condition in Western society,
affecting 1 in 20 adults [2]. Despite improvements in diagnosis and treatment,
approximately 50% of those who undergo a potentially curative resection die within 5 years,
the majority due to metastatic disease [3, 4]. Even patients with early stage cancers may also
succumb to the effects of metastatic disease [2].
The extracellular matrix (ECM) is produced and regulated by stromal cells and influences
the growth of normal and neoplastic cells [1]. The desmoplastic reaction (DR) associated
with invasive malignancy is characterised by dysregulated matrix turnover, with degradation
of normal type IV collagen-rich basement membrane and accumulation of fibrillar collagens
(predominantly type I) [5, 6]. In breast [7], pancreatic [8] and lung cancer [9] it has been
suggested that changes in the tumour microenvironment due to the DR may benefit the
tumour by enhancing proliferation, inducing a more invasive malignant phenotype, and
increasing chemoresistance [6, 8-11]. Whilst there is increasing evidence for a tumour DR in
primary malignancy far less is known about this axis in metastatic disease. Determining the
role of the DR in metastatic disease is important because malignant tumours are able to seed
a normal organ and elicit a desmoplastic wound healing response that may, in turn, influence
the behaviour of the metastatic population. In contrast many primary cancers develop in a
pre-existing inflammatory environment. Understanding the role of the DR in supporting
metastatic cancer may inform therapeutic strategies.
In primary lung cancers the effects of DR on tumour are integrin mediated [9]. Integrins are
cell surface receptors which, upon ligation with specific epitopes in the ECM, activate
intracellular signalling pathways that regulate genes crucial for growth, differentiation [12]
and apoptosis [13]. Intact and denatured collagens present a range of integrin ligands,
including those for β1 [14] and αv [15, 16] integrins. Over-expression of these integrin sub-
types might be important in the development of many epithelial cancers [17, 18]. A
pronounced DR is known to be an independent poor prognostic factor in patients with
colorectal carcinoma [19]. To date the limited numbers of in vitro studies examining the
effect of matrix components on colorectal carcinoma cell growth have produced
contradictory results [20, 21] and no unifying molecular mechanism has been defined to
explain the poor prognosis associated with the development of a florid DR in primary or
metastatic cancer.
In this study we have characterised the DR and integrin expression in partial hepatectomy
specimens performed for hepatic colorectal carcinoma metastases and demonstrated how
specific components of the desmoplastic matrix mediate a growth and survival advantage to
colorectal carcinoma cells via integrins. We also demonstrate the importance of differential
integrin expression by the cancer in vivo in hepatic metastases and describe a differential
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pattern of integrin expression for colorectal carcinomas with different metastatic
phenotypes. Finally we demonstrate, mechanistically, the importance of collagen I
degradation in regulating colorectal carcinoma cell growth, in particular those carcinoma
cells with an aggressive metastatic phenotype. The key role played by the DR in colorectal
carcinoma growth and survival identifies this process as a potential therapeutic target in the
treatment of metastatic colorectal carcinoma.
Materials and Methods
Cell culture
Cells were cultured under standard conditions at 37°C and 5% CO2. HT-29 cells were
obtained from the European Cell and Culture Collective (Porton Down, Wiltshire, UK) at
passage number 140. HT-29 is a human colorectal carcinoma cell line derived from a
primary grade 2 adenocarcinoma in 1964 and extensively studied since. The baseline
parental cell line with the lowest metastatic potential has been used although variants with
more metastatic potential have been established [22]. The KM12 cell line series (A kind gift
of Professor IJ Fidler MD Anderson centre, Houston, TX, USA) consisting of progressively
more aggressive liver metastasising variants derived from the original human KM12c cell
line by intrasplenically injecting KM12c cells into nude mice and extracting cells from the
resultant liver metastases, repeated several times to establish each metastatic line [23], were
obtained at passage 12 (KM12c) and passage 21 (KM12SM). HT-29 and KM12c cell lines
are poorly metastatic, and the KM12SM cell line is highly metastatic.
Collagen preparation
Collagens were dissolved in sterile 0.1 mM acetic acid to a final concentration of 1 mg/ml
and plated at 15 μg/cm2. In each experiment a control of untreated tissue culture plastic was
included. The matrix layers were blocked with 0.1% (w/v) bovine serum albumin. The Col
1a1r/r mice [24] produce type I collagen highly resistant to matrix metalloproteinase (MMP)
digestion (A kind gift of Professor S Krane, Harvard medical school, MA, USA). Type I r/r
collagen and its wild type control were extracted from mouse tails using the method of
Cawston and Barrett [25].
Tinctorial and immunohistochemical staining
Samples were obtained from 10 separate patients after appropriate consent (LREC No:
215/99), who had undergone partial hepatectomy for metastatic colorectal carcinoma, and
fixed in formalin. Sections were stained using a 0.1% picrosirius red solution (w/v) [26] or
immunostained as described [27]. Negative controls using non-immune IgG instead of
primary antibodies showed no staining. The primary antibodies and pre-treatments used
were; Collagen I (Microwave, pH 6, Clone Col-1, Abcam, Cambridge, UK); Collagen IV
(Pronase, Clone CIV 22, Dako Ely, Cambridgeshire, UK); α-smooth muscle actin
(Microwave, pH 6, Clone 1A4, Sigma, Poole, Dorset, UK); β1 integrin (Pronase, Clone
4B7R, Santa Cruz, CA, USA); αvβ3 integrin (Microwave, pH 8, ab7167, Abcam,
Cambridge, UK) and αvβ5 integrin (Microwave, pH 8, Clone 2Q1009, United States
Biological, Swampscott, MA, USA). Analysis of the sections was undertaken by two
pathologists who assessed the pattern and intensity of staining.
Clonogenic assays
Cells were cultured on uncoated plastic or type I or IV collagen in low serum media, or low
serum media containing FU, for 48-56 hours. Cells were seeded in quadruplicate at 200
cells/well and left for 8 to 14 days until colonies had formed. Colonies were counted after
Giemsa staining. The number of colonies (>16 cells) formed by cells exposed to FU was
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divided by the number of colonies in the untreated pair, giving an index of cell viability for
each substratum.
Measurement of [3H]-thymidine incorporation
The effect cell-matrix interactions on proliferation was determined by measuring [3H]-
thymidine incorporation. Experiments were conducted in triplicate in 24-well plates.
Incorporation of [3H]-thymidine into cell DNA was determined as described [8]. When
comparing proliferation of cancer cells on uncoated plastic vs. collagens, differences in cell
adhesion were controlled by quantifying total DNA using PicoGreen Reagent (Invitrogen
Ltd, Paisley, UK) in parallel triplicate wells. The results were expressed as
counts.min−1.ng−1 DNA.
Neutralising antibody experiments
Neutralising antibodies used were: β1 integrin (Clone 4B4-azide free, Beckmann Coulter,
High Wycombe, Buckinghamshire, UK); αvβ3 and αvβ5 integrins (Clones LM609 and
P1F6-azide free, Chemicon, Chandlers Ford, Hampshire, UK).
Cell adhesion assay
Cells were pre-incubated with appropriate antibody (5-20 μg/ml), IgG control (Ancell
antibodies, USA) or no antibody for 15 minutes before plating into uncoated or collagen
coated wells in 10% fetal calf serum. After culturing under standard conditions for 2 hours,
supernatants were removed and the wells washed to remove non-adherent cells. Adherent
cells were fixed with formaldehyde, and stained with 1% methylene blue. Methylene blue
was released from cells with 0.5 M HCl and absorbance measured at 620nm.
Effect of neutralising antibodies on cell proliferation
5 μg/ml β1 integrin neutralising antibody or control IgG was pre-incubated with cells for 15
minutes before plating, and [3H]-thymidine incorporation determined as described. For
αvβ3 and αvβ5 integrin neutralising antibodies (5-10 μg/ml) it was possible that cell-
mediated degradation of matrix was necessary to reveal epitopes so cells were plated out as
described then switched to low serum media for 8 hours. The neutralizing antibody and
controls were added in low serum media, left for a further 8 hours and [3H]-thymidine
incorporation determined. DNA was measured in parallel wells to correct for potential
differing adherent cell numbers.
Immunoblot analysis
1×106 cells were added to flasks coated with different matrices, and cultured for 16 hours.
The media was changed to low serum media after washing and the cells cultured for 36
hours before processing.
To determine the amount of apoptosis as a result of FU treatment, Poly-ADP Ribose
Polymerase (PARP) cleavage was assessed. After 8 hours of culture in low serum conditions
FU (0-50 μg/ml) was added for 48-56 hours.
Cell monolayers were harvested into RIPA buffer containing mammalian protease inhibitors
(Sigma, Poole, Dorset, UK). Protein concentrations were determined using the bicinchoninic
acid protein assay kit (BCA-1, Sigma, Poole, Dorset, UK). Samples were prepared
according to the Invitrogen Nupage protocol. 10-50 μg of protein was separated on Nupage
4-12% gels with MOPS running buffer. Samples were unreduced except those assessed for
PARP cleavage. Proteins were transferred onto a PVDF membrane and the following
antibodies applied; αv integrin, 1:1,000 (Clone AV1, Chemicon, Chandlers Ford,
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Hampshire, UK); β1 integrin, 1:1,000 (Clone JB1A, Chemicon, Chandlers Ford, Hampshire,
UK); β3 integrin, 1:1,000 (Clone BB10, Chemicon, Chandlers Ford, Hampshire, UK); β5
integrin, 1:500 (Clone 343.11D1, Calbiochem, Beeston, Nottingham, UK); PARP, 1:1,500
(Clone C2-10, R&D systems, Abingdon, Oxon, UK). Equal sample loading was determined
by immunoblotting for β-actin, 1:10,000 (Clone AC15, Sigma, Poole, Dorset, UK). Blots
were processed using Western Breeze anti-mouse chemiluminescent detection system
(Invitrogen Ltd, Paisley, UK), and the images captured using a Biorad FluorSmax imager
(Biorad life sciences, Hemel Hempstead, Hertfordshire, UK).
Detection of apoptosis using flow cytometry
Apoptosis was quantified using the Annexin V Apoptosis detection kit (Calbiochem, PF032)
utilizing appropriate controls for Annexin V and propidium iodide (PI) staining as directed
by the manufacturer's protocol. A positive control was provided by colorectal carcinoma
cells treated with a 3% formaldehyde solution. Samples were prepared using the same
protocol as that used for determining the amount of PARP cleavage, and were analysed
using the FACSCalibur system (Beckton Dickinson, UK).
Cell proliferation on Type I r/r collagen
The [3H]-thymidine and Pico green proliferation assay, as previously described, were
performed for colorectal carcinoma cells cultured on proprietary collagen I (Sigma, Poole,
Dorset, UK), r/r and wild type collagen I. The αvβ3 and αvβ5 integrin neutralising antibody
experiments were also performed, as described, with KM12SM cells grown on these
matrices.
Statistical Analysis
All results are expressed as means ± 95% confidence intervals and all experiments were
repeated a minimum of three times. Statistical significance was assessed using Student's t-
test.
Results
Staining pattern of collagens and integrins in resected liver
Picrosirius red staining demonstrated absence of fibrillar collagen within normal liver except
for walls of vessels within portal tracts (Figure 1a). A matrix-rich stromal reaction was
present within metastatic colorectal carcinoma (Figure 1b). Fibrillar collagen-rich
desmoplasia was most dense in poorly differentiated areas of tumour, often enveloping
individual tumour cells. The deposited matrix was populated by increased numbers of α-
smooth muscle actin (α-sma) positive hepatic myofibroblasts (Figure 1c). The fibrotic
neomatrix consisted predominantly of collagens I and III (Figure 1d). Immunostaining for
collagen IV demonstrated disruption of the normal pattern within the metastasis compared to
adjacent normal liver. Most residual collagen IV within the metastases was associated with
fibrillar collagen bands (Figure 1e).
β1 integrin expression was demonstrated in normal liver tissue and throughout the colorectal
carcinoma metastases (Figure 2a). Within metastases β1 integrins were expressed by both
tumour and stromal cells at higher levels compared to normal liver. However, the pattern of
β1 integrin expression within the metastases was irregular, being most dense and uniformly
distributed in well differentiated areas of the tumour, and often less strongly expressed or
absent in poorly differentiated areas (Figure 2b).
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In well differentiated areas of the metastases αvβ5 integrin was expressed at very low levels
(Figure 2c) in contrast to stronger expression within poorly differentiated areas (Figure 2d).
Expression was highest along the invading margin of the metastases (Figures 2e).
αvβ3 integrin expression has been previously described in primary human adenocarcinoma
[28] and was strong throughout the metastases. Although expression appeared to be highest
in poorly differentiated areas, the differences were not as marked as those identified for
αvβ5 integrin expression (data not shown).
Collagens regulate colorectal carcinoma cell proliferation
Having demonstrated abundant collagen I in hepatic colorectal carcinoma metastases in vivo
we examined the effect of collagen I on tumour cell growth and chemoresistance in vitro.
Culture on collagen I significantly increased proliferation of all colorectal carcinoma cell
lines compared to tissue culture plastic and collagen IV. Collagen IV significantly inhibited
proliferation of HT-29 and KM12c cells compared to tissue culture plastic and collagen I.
The anti-proliferative effect of type IV collagen was less marked in KM12SM cells (Figure
3a).
Collagens regulate colorectal carcinoma cell response to chemotherapeutic agents
Clonogenic assays were utilised to determine colorectal carcinoma cell survival after
exposure to the chemotherapeutic agent FU. The clonogenic indices for the HT-29, KM12c
and KM12SM cell lines grown on tissue culture plastic without treatment were 0.433, 0.50
and 0.52 respectively. A dose response curve to FU was determined for each cell line. The
IC-50 used for subsequent experiments for each cell line were: HT-29, 1 μg/ml for 56 hours;
KM12c, 0.125 μg/ml for 48 hours; KM12SM, 0.25 μg/ml for 48 hours.
Clonogenic assays demonstrated a significant survival advantage for HT-29, KM12c and
KM12SM cells when grown on collagen I compared to collagen IV following exposure to
FU (Figure 3b). In the absence of FU the different matrix substrata had no significant effect
on cell survival, with similar colony numbers and sizes observed. The survival benefits of
collagen I to KM12SM cells, although still significant, were reduced in magnitude in
comparison to HT-29 and KM12c cells.
Collagen I enhances chemoresistance
Enhanced survival is the product of both changes in proliferation and apoptosis. The
apoptotic response of colorectal carcinoma cell lines grown on different matrices to FU was
assessed by analysing PARP cleavage. A dose response curve for each cell line was
determined. For cells grown on collagen I and IV and exposed to FU, the percentage of
uncleaved and cleaved PARP was then determined by densitometric analysis of
immunoblots, and the ratio of cleaved/uncleaved PARP was compared.
There was a significant reduction in PARP cleavage in response to FU in each cell line when
cultured on collagen I, compared to collagen IV (Figure 4a and b). The chemoprotective
effect of type I collagen was greatest for HT-29 & KM12c cells where apoptosis was
reduced by approximately 20% (p<0.05). Collagen I reduced the amount of PARP cleavage
in the KM12SM line by approximately 10%.
Apoptosis was also determined after identical treatment regimens by FACS analysis
following Annexin V/PI staining. This confirmed the results obtained using the clonogenic
and PARP assays (Figures 4a and c).
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Integrin neutralisation inhibits colorectal carcinoma cell adhesion and proliferation
After demonstrating that collagen I regulates colorectal carcinoma cell growth and survival,
and that colorectal carcinoma cells express β1 and αv integrins in vivo, we examined the
role of these integrins in mediating cell growth and survival. Immunoblotting demonstrated
that KM12 cell lines differed in integrin expression depending on their metastatic potential
(Data not shown). The highly metastatic KM12SM line expressed αv, β3 and β5 integrins at
higher levels, especially when cultured on collagens, compared with the poorly metastatic
KM12c line.
Neutralising antibodies were used to examine the contribution of integrin sub-units to
colorectal carcinoma cell adhesion. β1 integrin neutralising antibody exerts a significant
concentration dependent antagonism of cellular adhesion of between 40-60% for each cell
line on both collagen I and IV (Data not shown). In contrast, αvβ3 and αvβ5 neutralising
antibodies had minimal effect on adhesion.
β1 integrin neutralisation reduced proliferation for all cell lines in a concentration dependent
manner, indicating that β1 integrin has an important role in regulating both adhesion and
proliferation (Figure 5a). Although neutralisation of αvβ3 integrin had no effect on cell
adhesion, it did significantly reduce proliferation of KM12SM cells on collagens I and IV
(but not tissue culture plastic) in a concentration dependent manner. Previous work has
shown reduced survival of colorectal carcinoma cell lines after treatment with S247 (highly
potent and selective antagonist that inhibits binding of purified αvβ3 to vitronectin) [29].
There was no effect on proliferation of HT-29 and KM12c cells on any substratum (Figure
5b). A similar anti-proliferative effect was demonstrated on collagens with αvβ5 integrin
neutralising antibody in both metastatic and poorly-metastatic cell lines (Figure 5c). The
magnitude of this effect was greatest for KM12SM cell line.
Prevention of collagen I breakdown attenuates the proliferative effect on colorectal
carcinoma cells
The inhibition of collagen-dependent colorectal carcinoma cell proliferation by αvβ3 and
αvβ5 blockade suggested that these integrins encountered stimulating ligands within the
collagen. It has been reported that ligands for these integrins are hidden in intact collagen
but revealed by collagen degradation [15, 16].
We used MMP resistant type I r/r collagen as a dominant negative ligand to determine
whether exposure of cryptic αv binding epitopes mediates the growth promoting effect of
collagen I. Cell lines cultured on type I r/r collagen proliferated less compared with cells
cultured on wild-type and proprietary collagen type I (Figure 6a). Proliferation of KM12SM
cells was most inhibited by culture on type I r/r collagen.
This suggested that colorectal carcinoma cells degrade matrix to reveal αv integrin ligands
as they adopt a more aggressive metastatic phenotype, in turn promoting their own growth.
To examine this possibility proliferation assays were performed using integrin neutralisation
on the different types of collagen I. Antibodies to the αv subunit had no influence on
KM12SM proliferation on type I r/r collagen. In contrast this antibody significantly reduced
proliferation of KM12SM cells on both the wild type control and proprietary collagen I
(Figure 6b).
Discussion
These studies provide clear support for the importance of a desmoplastic reaction in the
development, growth and chemoresistance of hepatic colorectal carcinoma metastases.
Activated liver myofibroblasts present in these areas are a likely source of these collagens.
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Colorectal carcinoma cell lines derive a growth and survival advantage, and increased
chemoresistance, as a result of contact with collagen I, a major component of this
desmoplastic reaction. There is clear evidence that colorectal carcinoma integrin expression
(specifically αv) and turnover of collagen I enhance growth.
Resected hepatic colorectal carcinoma metastases showed a desmoplastic reaction,
consisting predominantly of collagen I forming discrete fibrils throughout the stroma.
Interestingly this was often at its most dense in poorly differentiated areas. Colorectal
carcinoma cells may provoke an inflammatory reaction within the liver [30], which initiates
the hepatic wound healing response, with transdifferentiation of hepatic stellate cells into
fibrogenic hepatic myofibroblasts. In vitro studies have suggested that interactions between
colorectal carcinoma cells and stromal cells contribute to the development of primary
colorectal cancers [31], and studies using animal models suggest that redistribution and
expansion of myofibroblasts play an important role in the formation of established hepatic
colorectal carcinoma metastases [32]. A desmoplastic response in these circumstances can
be viewed as a fibrogenic response to inflammation. Successful colorectal carcinoma cell
clones may have been selected for their ability to respond to components of the desmoplastic
reaction with enhanced proliferation and survival. Indeed, studies in several different
primary cancers [7, 33] suggest that this response may be a feature of aggressive neoplasms.
Previous studies investigating the apoptotic and proliferative responses of colorectal
carcinoma cells to different matrix components have produced highly variable results [20,
21]. Our studies demonstrate that interstitial collagens consistently enhance colorectal
carcinoma cell growth. Within the desmoplastic area in vivo the alteration in collagen IV
distribution may also be important to the colorectal carcinoma phenotype. Our
immunohistochemical staining showing dysregulated deposition was specific for the α1 & 2
chains of collagen IV. Type IV collagen possess many sequences on the α2, 3 and 6 chains
that inhibit proliferation, migration, and MMP production in other cancer cells [34, 35]. It is
of interest that the inhibitory effects of collagen IV on colorectal carcinoma cell proliferation
in vitro depended on the metastatic potential of the clone. Collagen I, in contrast, was
always growth promoting. Poorly metastatic clones show a reduction in proliferation when
cultured on collagen IV but aggressively metastatic clones do not. Thus the ability to
establish growth, overcoming inhibitory influences, within a virgin collagen IV-rich
environment is a feature of aggressive malignancy.
Antagonisation of β1 integrin reduced both adhesion and proliferation for all colorectal
carcinoma cell clones. However, β1 integrin blockade had a more marked effect on
proliferation of the poorly metastatic colorectal carcinoma cells. In contrast, highly
metastatic colorectal carcinoma cells express αv integrins at higher levels, and the inhibition
of proliferation by αvβ3 and αvβ5 blockade demonstrated their key growth regulatory role.
Integrin blockade of this nature is consistent with integrin gene-deletion in other systems,
supporting true integrin antagonism [36]. Despite some debate existing about the agonist
effects of integrin blocking agents with respect to angiogenesis, our data is consistent with
true antagonism. The in vivo data demonstrating the differential expression of different
integrin sub-types within hepatic colorectal carcinoma metastases supports our in vitro data,
showing different patterns of integrin expression dependent on the malignant phenotype of
colorectal carcinoma. Through enhanced expression of αv integrins the highly metastatic
colorectal carcinoma cell clones may respond to a wider repertoire of matrix components
and proliferate not only on collagen I but also collagen IV. The antibody used for staining
of, and blockade of, β1 complexes does not differentiate between specific complexes, this
data does demonstrate the importance of these complexes.
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Degradation of both collagens IV and I reveals key growth regulatory RGD sequences that
can be ligated by αv integrin sub-types. RGD sequences are expressed by degraded
collagens, fibronectin and vitronectin [15, 16], and are important in the development of
other malignancies [17, 37]. The effect of αv integrin blockade on colorectal carcinoma
cells grown on collagens suggests that cells encountered these growth promoting ligands
after collagen degradation, substantiated by the results obtained for cells grown on r/r
collagen I combined with αv integrin blockade.
Exposure of colorectal carcinoma cells to collagen I is associated with a more invasive
phenotype [38] and up-regulation of αvβ5 integrins may be associated with invasion [39].
There may, therefore, be complex interplay between matrix components and colorectal
carcinoma, with integrins acting as intermediates. Alterations in integrin expression,
conformation and adhesiveness are under the control of ras signalling pathways (inside-out
signalling) [12, 40], but can also be influenced by the ECM (outside-in signalling) [1, 12].
Components of the desmoplastic matrix could modify the properties of integrins expressed
by colorectal carcinoma cells. Indeed our immunoblotting studies support this by showing
increased αv, β3 and β5 expression in more highly metastatic clones.
Candidate MMPs involved in the development of hepatic colorectal carcinoma metastases
include MMPs-2, 7, 9 and 14 [41-43]. Our own studies using gelatin zymography (Data not
shown) have shown that colorectal carcinoma cells produce active MMP-2 and 9, whilst
hepatic myofibroblasts express higher amounts of MMP-2, 9 and 14 [44]. The importance of
matrix remodelling by colorectal carcinoma-derived MMPs in generating matrix-derived
proliferative signals to carcinoma cells is illustrated by our studies showing that MMP-
resistant r/r collagen I provides a poorer proliferative stimulus than normal type I collagen.
In r/r collagen I, collagenase-resistance prevents the initial cleavage [24] and unwinding that
reveals αv binding epitopes. By demonstrating a reduction in proliferation in response to r/r
collagen I we have further supported our αv integrin neutralising antibody experiments. This
experimental approach is particularly robust as it obviates the need to identify or inhibit
specific MMPs involved in the process of matrix remodelling.
Much data also exists for the role of non-integrin mediated cell-matrix interactions. CD44
has been implicated in promoting tumour metastasis growth but, reflecting the complexity of
the extracellular milieu, this may be closely related to both integrin expression and MMP
activity [45]. There may also be a role for discoidin domain receptors (DDR) which are
known to be up regulated in colorectal carcinoma and are integrin-independent [46].
Collagen I and III are ligands for both DDR1 and DDR2 although only when collagen has
an intact structure since no signalling is observed with heat-denatured collagen. Our finding
that collagenase-resistant r/r collagen I provides a poor proliferative stimulus is inconsistent
with DDRs playing a fundamental role since the 3 dimensional structure of collagen I is
preserved in r/r collagen, suggesting that DDRs should still be active [47].
We have demonstrated evidence in vivo of a pronounced desmoplastic reaction in hepatic
colorectal carcinoma metastases, and that colorectal carcinoma cells express β1 and αv
integrins. We propose that the desmoplastic reaction is a dynamic phenomenon, with
degradation of normal collagen IV-rich matrix occurring simultaneously with deposition of
fibrillar collagens. The desmoplastic reaction arises as a consequence of the provocation of a
classical wound healing response with activation of hepatic myofibroblasts by metastatic
tumour cells. The resultant fibrotic neomatrix accumulation may provide a rapidly
replenishing resource of neo-epitopes that could function as ligands for growth regulatory
integrins expressed by colorectal carcinoma cells. This environment might select for
colorectal carcinoma cells expressing the collagen I binding integrins. As the collagen IV-
rich matrix in the space of Disse and the desmoplastic neomatrix rich in collagen I are
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degraded by metastatic cells, possibly in association with hepatic myofibroblasts, key
growth regulatory neo-epitopes are revealed that act as ligands for αv integrins. This process
may perpetuate the fibrotic response as hepatic myofibroblast proliferation is enhanced by
ligation of αvβ3 integrin [48]. The differential integrin expression characterises a more
aggressive malignant phenotype in which the growth inhibitory effects of collagen IV are
lost. These data suggest that inhibiting desmoplastic matrix synthesis or turnover could offer
new therapeutic options in patients with metastatic colorectal carcinoma.
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Figure 1.
Expression of collagen within desmoplastic reaction. (a) In normal liver picrosirius red
positive fibrillar collagen is only present within portal tracts (arrowed). (b) In areas of
tumour desmoplasia picrosirius red positive fibrillar collagen is abundant. This is most dense
in association with the most poorly differentiated areas. (c) Activated hepatic myofibroblasts
demonstrated by α-smooth muscle actin immunopositivity are plentiful within the deposited
desmoplastic matrix. (d) Collagen I is the major component of desmoplastic neomatrix. (e)
In normal liver collagen IV is found in the space of Disse (below line) but within areas of
tumour desmoplasia deposition of collagen IV is denser and more widespread. Images
representative of staining patterns identified in livers of 10 different patients. 100x
magnification.
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Figure 2.
Expression of β1 and αv integrins within hepatic colorectal carcinoma metastases. (a)
Normal liver has a uniform pattern of β1 integrin expression on hepatocyte basement
membranes (upper right) whilst expression was increased and disorganised in areas of
tumour desmoplasia (lower left). (b) Less β1 integrin expression is observed in poorly
differentiated areas of tumour. (c) Well differentiated tumour expresses minimal αvβ5
whilst there is marked expression by epithelial and stromal cells in poorly differentiated (d)
areas. (e). αvβ5 integrins were most highly expressed at the invading margin of the tumour.
Images representative of staining patterns identified in livers of 10 different patients. 100x
magnification (e, 400x magnification).
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Figure 3.
Influence of different matrices on colorectal adenocarcinoma cell proliferation and survival.
(a) Collagen I was significantly growth promoting compared to collagen IV and tissue
culture plastic (control) in all cell lines. The inhibitory effects of collagen IV on cell growth
were not observed in KM12SM cells. (b) Colorectal carcinoma cell lines gain a significant
survival advantage after FU exposure when cultured on collagen I compared to tissue culture
plastic and collagen IV. *, p<0.05.
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Figure 4.
Reduction in apoptosis in response to FU with culture on collagen I compared to collagen
IV. (a) Colorectal adenocarcinoma cell line apoptosis after exposure to chemotherapy (FU)
is reduced by culture on collagen I compared with collagen IV, measured by both PARP
cleavage and Annexin V/PI staining and FACS analysis. Results expressed as means ± 95%
confidence intervals. *, p<0.05. (b) Representative immunoblot from which PARP cleavage
was determined after densitometry. (c) Representative plot of FACS analysis for Annexin V
(FL1-H, x-axis) and PI (FL2-H, y-axis) staining of FU treated HT-29 cells cultured on either
collagen I (left) or collagen IV (right) with percentages indicated (L, live; N, necrotic; LA,
late apoptotic; EA, early apoptotic).
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Figure 5.
Effect of integrin neutralization on proliferation of colorectal adenocarcinoma cell lines on
different sub-cellular matrices. (a) β1 integrin neutralizing antibody significantly reduced
proliferation on collagen I and IV. (b) αvβ3 integrin neutralisation significantly reduced
proliferation of KM12SM cells on collagen I and IV. (c) αvβ5 integrin neutralisation
significantly reduced proliferation on collagen I and IV. Expressed as means ± 95%
confidence intervals, compared with IgG isotype control. *, p<0.05 vs. control antibody.
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Figure 6.
Influence of αv integrin neutralization on colorectal adenocarcinoma cell line proliferation
on wild type and r/r type I collagens. (a) Proliferation of colorectal adenocarcinoma cell
lines was reduced when grown on r/r collagen I compared to proprietary (Collagen I) and
wild-type (WT) collagen I. Expressed as means ± 95% confidence intervals, compared with
culture on tissue culture plastic. *, p<0.05 r/r collagen I vs. WT and propriety collagen I. (b)
αvβ3 and αvβ5 neutralisation significantly reduced KM12SM proliferation on proprietary
and wild type collagen I but not when cultured on r/r collagen I. Expressed as means ± 95%
confidence intervals, compared with IgG control. *, p<0.05.
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